Gamida Cell Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$2.0M
Doctors Paid
36
Transactions
132
2024 Total
$824,454
Payment Breakdown by Category
Research$1.7M (88.5%)
Consulting$223,769 (11.4%)
Food & Beverage$2,229 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.7M | 76 | 88.5% |
| Consulting Fee | $223,769 | 25 | 11.4% |
| Food and Beverage | $2,229 | 31 | 0.1% |
Payments by Type
Research
$1.7M
76 transactions
General
$225,998
56 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| EVALUATION OF SAFETY AND EFFICACY OF ALLO GDA-201 NK CELLS IN PATIENTS WITH RELAPSED REFRACTORY B CELL NHL | $583,470 | 0 | 17 |
| EVALUATION OF SAFETY AND EFFICACY OF ALLO GDA-201 CELLS IN PATIENTS WITH RELAPSED/REFRACTORY B CELL NHL | $445,551 | 0 | 20 |
| STEM CELL TRANSPLANTATION WITH NICORD (OMIDUBICEL) VS STANDARD UCB IN PATIENTS WITH LEUKEMIA, LYMPHOMA, AND MDS | $429,659 | 0 | 17 |
| EXPANDED ACCESS OF OMIDUBICEL, FOR ALLOGENEIC TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES | $248,458 | 0 | 18 |
| LONG TERM FOLLOW UP PROTOCOL FOR NICORD\CORDIN (OMIDUBICEL) PATIENTS | $33,726 | 0 | 4 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Medical Oncology | $182,619 | 1 | $182,619 |
| Hematology & Oncology | $27,273 | 15 | $1,818 |
| Internal Medicine | $6,204 | 9 | $689.28 |
| Hematology | $6,093 | 2 | $3,047 |
| Pediatric Hematology-Oncology | $1,697 | 2 | $848.44 |
| Pediatrics | $1,650 | 1 | $1,650 |
| Student in an Organized Health Care Education/Training Program | $129.30 | 3 | $43.10 |
| Clinical Nurse Specialist | $112.18 | 1 | $112.18 |
| Physician Assistant | $112.18 | 1 | $112.18 |
| Family | $109.31 | 1 | $109.31 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Ivan Borrello, M.d, M.D | Medical Oncology | Tampa, FL | $182,619 | $0 |
| Dr. Leland Metheny, M.d, M.D | Hematology | Cleveland, OH | $6,050 | $0 |
| Dr. Koen Van Besien, M.d, M.D | Hematology & Oncology | Cleveland, OH | $5,000 | $0 |
| Mitchell Horwitz | Hematology & Oncology | Durham, NC | $3,962 | $0 |
| Filippo Milano, M.d, M.D | Hematology & Oncology | Seattle, WA | $3,609 | $0 |
| Jonathan Gutman, Md, MD | Hematology & Oncology | Aurora, CO | $2,550 | $0 |
| Richard Maziarz, Md, MD | Hematology & Oncology | Portland, OR | $2,550 | $0 |
| Patrick Stiff, Md, MD | Hematology & Oncology | Maywood, IL | $2,550 | $0 |
| George Yaghmour | Hematology & Oncology | Los Angeles, CA | $2,550 | $0 |
| Dr. Sagar Patel, M.d, M.D | Internal Medicine | Edina, MN | $2,191 | $0 |
| Julio Alvarenga Thiebaud, M.d, M.D | Hematology & Oncology | Dallas, TX | $2,093 | $0 |
| Dr. Veronika Bachanova, Md, MD | Internal Medicine | Minneapolis, MN | $2,000 | $0 |
| Ms. Gabriela Sanchez Petitto, Md, MD | Hematology & Oncology | Columbus, OH | $1,950 | $0 |
| Dr. Sachit Patel, M.d, M.D | Pediatrics | Omaha, NE | $1,650 | $0 |
| Caridad Martinez, Md, MD | Pediatric Hematology-Oncology | Houston, TX | $1,650 | $0 |
| Amer Assal, M.d, M.D | Internal Medicine | New York, NY | $1,650 | $0 |
| Dr. Praveen Ramakrishnan Geethakumari, M.d, M.D | Hematology & Oncology | Dallas, TX | $145.36 | $0 |
| Kadee Raser, Pa, PA | Physician Assistant | Ann Arbor, MI | $112.18 | $0 |
| Donna Salzman | Hematology & Oncology | Birmingham, AL | $112.18 | $0 |
| Joan Adams, Aprn-Cns, APRN-CNS | Clinical Nurse Specialist | Oklahoma City, OK | $112.18 | $0 |
| Pepita Jean, Arnp, ARNP | Family | Miami, FL | $109.31 | $0 |
| Dr. Girish Kunapareddy, M.d, M.D | Internal Medicine | Terre Haute, IN | $106.54 | $0 |
| Dr. Sayed Mehdi Hamadani, M.d, M.D | Hematology & Oncology | Milwaukee, WI | $100.84 | $0 |
| Dr. Eric Huselton, M.d, M.D | Internal Medicine | Rochester, NY | $68.56 | $0 |
| Dr. Zachary Crees, Md, MD | Internal Medicine | Saint Louis, MO | $68.56 | $0 |
About Gamida Cell Inc.
Gamida Cell Inc. has made $2.0M in payments to 36 healthcare providers, recorded across 132 transactions in the CMS Open Payments database. In 2024, the company paid $824,454. The top product by payment volume is OMISIRGE ($937,842).
Payments were distributed across 10 medical specialties. The top specialty by payment amount is Medical Oncology ($182,619 to 1 doctors).
Payment categories include: Food & Beverage ($2,229), Consulting ($223,769), Research ($1.7M).
Gamida Cell Inc. is associated with 1 products in the CMS Open Payments database.